Sorbitol Is a Severity Biomarker for <scp>PMM2‐CDG</scp> with Therapeutic ImplicationsAnna N. Ligezka, Éva Morava, Akhilesh Pandey et al.|Annals of Neurology|2021Cited by 57
<scp>TRIT1</scp> defect leads to a recognizable phenotype of myoclonic epilepsy, speech delay, strabismus, progressive spasticity, and normal lactate levelsEwout Muylle, Éva Morava, Huafang Jiang et al.|Journal of Inherited Metabolic Disease|2022Cited by 18
Coagulation abnormalities in a prospective cohort of 50 patients with PMM2-congenital disorder of glycosylationDiederik De Graef, Éva Morava, Christina Lam et al.|Molecular Genetics and Metabolism|2023Cited by 16
Coagulation Abnormalities in a Prospective Cohort of 50 Patients with PMM2-Congenital Disorder of GlycosylationDiederik De Graef, Éva Morava, Christina Lam et al.|SSRN Electronic Journal|2023Cited by 0